Company Overview and News


Add MSTY
to your dashboard

Headline News

Mainstay Medical???s ReActiv8-B Clinical Trial Passes Mid-point

2017-08-03 devicespace
Mainstay Medical International plc (“Mainstay” or the “Company”, Euronext Paris: MSTY.PA and ESM of the Irish Stock Exchange: MSTY.IE), a medical device company focused on bringing to market ReActiv8®, an implantable restorative neurostimulation system to treat disabling Chronic Low Back Pain (“CLBP”), announces that over half the required number of implants in the ReActiv8-B Clinical Trial have been performed.

Mainstay Medical?s ReActiv8-B Clinical Trial Passes Mid-point

2017-08-03 londonstockexchange
Mainstay Medical International plc (“Mainstay” or the “Company”, Euronext Paris: MSTY.PA and ESM of the Irish Stock Exchange: MSTY.IE), a medical device company focused on bringing to market ReActiv8®, an implantable restorative neurostimulation system to treat disabling Chronic Low Back Pain (“CLBP”), announces that over half the required number of implants in the ReActiv8-B Clinical Trial have been performed.

Mainstay Medical To Host Key Opinion Leader Event On The Chronic Low Back Pain Treatment Landscape

2017-06-22 devicespace
Mainstay Medical to Host Key Opinion Leader Event on the Chronic Low Back Pain Treatment Landscape

Statement re Mainstay Medical to Host Key Opinion Leader Event on the Chronic Low Back Pain Treatment Landscape

2017-06-22 londonstockexchange
Mainstay Medical to Host Key Opinion Leader Event on the Chronic Low Back Pain Treatment Landscape

Mainstay Medical To Present At The Securities 2017 Life Sciences Conference

2017-06-15 devicespace
Mainstay Medical International plc (“Mainstay” or the “Company”, Euronext Paris: MSTY.PA and ESM of the Irish Stock Exchange: MSTY.IE), a medical device company focused on bringing to market ReActiv8®, an implantable restorative neurostimulation system to treat disabling Chronic Low Back Pain (“CLBP”), announces that Peter Crosby, Chief Executive Officer of Mainstay, will present at the JMP Securities 2017 Life Sciences Conference at the St.

Mainstay Medical to Present at the JMP Securities 2017 Life Sciences Conference

2017-06-15 londonstockexchange
Mainstay Medical International plc (“Mainstay” or the “Company”, Euronext Paris: MSTY.PA and ESM of the Irish Stock Exchange: MSTY.IE), a medical device company focused on bringing to market ReActiv8®, an implantable restorative neurostimulation system to treat disabling Chronic Low Back Pain (“CLBP”), announces that Peter Crosby, Chief Executive Officer of Mainstay, will present at the JMP Securities 2017 Life Sciences Conference at the St.

Mainstay Medical to Present at the Jefferies 2017 Global Healthcare Conference

2017-05-31 londonstockexchange
Mainstay Medical International plc (“Mainstay” or the “Company”, Euronext Paris: MSTY.PA and ESM of the Irish Stock Exchange: MSTY.IE), a medical device company focused on bringing to market ReActiv8®, an implantable restorative neurostimulation system to treat disabling Chronic Low Back Pain (“CLBP”), announces that Peter Crosby, Chief Executive Officer of Mainstay Medical, will present at the Jefferies 2017 Global Healthcare Conference in New York, from Tuesday 6th – Friday 9th June 2017.

Mainstay Medical To Present At The Conference

2017-05-16 devicespace
Mainstay Medical International plc (“Mainstay” or the “Company”, Euronext Paris: MSTY.PA and ESM of the Irish Stock Exchange: MSTY.IE), a medical device company focused on bringing to market ReActiv8®, an implantable restorative neurostimulation system to treat disabling Chronic Low Back Pain (“CLBP”), announces that Chief Executive Officer, Peter Crosby, will present at the UBS Global Healthcare Conference, taking place at The Grand Hyatt New York, New York, USA, Monday, May 22 – Wednesday, May 24.

Mainstay Medical to Present at the UBS Global Healthcare Conference

2017-05-16 londonstockexchange
Mainstay Medical International plc (“Mainstay” or the “Company”, Euronext Paris: MSTY.PA and ESM of the Irish Stock Exchange: MSTY.IE), a medical device company focused on bringing to market ReActiv8®, an implantable restorative neurostimulation system to treat disabling Chronic Low Back Pain (“CLBP”), announces that Chief Executive Officer, Peter Crosby, will present at the UBS Global Healthcare Conference, taking place at The Grand Hyatt New York, New York, USA, Monday, May 22 – Wednesday, May 24.

Mainstay Medical to Present at the Deutsche Bank 42nd Annual Health Care Conference

2017-04-28 londonstockexchange
Mainstay Medical International plc (“Mainstay” or the “Company”, Euronext Paris: MSTY.PA and ESM of the Irish Stock Exchange: MSTY.IE), a medical device company focused on bringing to market ReActiv8®, an implantable restorative neurostimulation system to treat disabling Chronic Low Back Pain (“CLBP”), announces that Chief Executive Officer, Peter Crosby, will present at the Deutsche Bank 42nd Annual Health Care Conference, at The InterContinental Boston Hotel, Boston, USA on Wednesday May 3rd at 3.

Mainstay Medical To Present At

2017-04-19 devicespace

Mainstay Medical to Present at the MedTech Strategist Innovation Summit: Dublin 2017

2017-04-19 londonstockexchange
Mainstay Medical International plc (“Mainstay” or the “Company”, Euronext Paris: MSTY.PA and ESM of the Irish Stock Exchange: MSTY.IE), a medical device company focused on bringing to market ReActiv8®, an implantable restorative neurostimulation system to treat disabling Chronic Low Back Pain (“CLBP”), announces that Chief Executive Officer, Peter Crosby, will present at the MedTech Strategist Innovation Summit: Dublin 2017, at The Shelbourne Hotel, Dublin, Ireland on 26th April, 2017 from 15.